Regeneron Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$737.63(as of Jan 16, 10:01 AM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regeneron Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$737.63
Ticker SymbolREGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,222
CountyUSA
Market Cap$79,929.4M
EBIDTA4,348.0M
10-Day Moving Average774.89
P/E Ratio17.37
20-Day Moving Average773.74
Forward P/E Ratio17.15
50-Day Moving Average738.91
Earnings per Share41.70
200-Day Moving Average608.89
Profit Margin38.89%
RSI43.92
Shares Outstanding103.3M
ATR20.86
52-Week High821.11
Volume865,534
52-Week Low475.17
Book Value30,957.8M
P/B Ratio2.57
Upper Keltner820.68
P/S Ratio5.58
Lower Keltner726.80
Debt-to-Equity Ratio820.68
Next Earnings Date01/30/2026
Cash Surplus-1,918.7M
Next Ex-Dividend DateUnknown
Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.
Regeneron Pharmaceuticals Inc In Our Stock Scanner
As of Jan 16, 2026
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.